Skip to main content
eScholarship
Open Access Publications from the University of California

RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML.

  • Author(s): Crews, Leslie A
  • Balaian, Larisa
  • Delos Santos, Nathaniel P
  • Leu, Heather S
  • Court, Angela C
  • Lazzari, Elisa
  • Sadarangani, Anil
  • Zipeto, Maria A
  • La Clair, James J
  • Villa, Reymundo
  • Kulidjian, Anna
  • Storb, Rainer
  • Morris, Sheldon R
  • Ball, Edward D
  • Burkart, Michael D
  • Jamieson, Catriona HM
  • et al.

Published Web Location

https://pdf.sciencedirectassets.com/274143/1-s2.0-S1934590915X00129/1-s2.0-S1934590916302508/main.pdf?X-Amz-Date=20191113T193243Z&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Signature=5534c933af102bbc1752a3f92d0b75a54a1960d854cfd1e68a7e50ccce727440&X-Amz-Credential=ASIAQ3PHCVTYUWRNVROG%2F20191113%2Fus-east-1%2Fs3%2Faws4_request&type=client&tid=prr-cd74e897-c20b-4f0c-8166-f19a69fc8892&sid=be69368064598146036af4a90cb41b35be3egxrqa&pii=S1934590916302508&X-Amz-SignedHeaders=host&X-Amz-Security-Token=IQoJb3JpZ2luX2VjEAsaCXVzLWVhc3QtMSJHMEUCIQCuuSPhQKQ6RSGRaZYNOTimIEYjeqBET4%2FglNpHO6PtegIgUlTCm0LcsCVZNq7www7gZT9m4qFPbB1KNYqvlSDI4CMq0AIINBACGgwwNTkwMDM1NDY4NjUiDI8gKWlll5lo73IwaSqtAs%2F1OLTCZJyRjsWau7o5RdAZR9MOIfMdqQ7orZapMgfwBGxJPFXoEOgLZjBEJr4ExtbB3tArTgnoaYEu%2Fp40Nn9a5v4ANYTqoiRRqiPQy5YJa8px4MeVDm8H8b9G9kf3D3GoM2pZghSC0LBaA8vVc6X599k3nDVWuxy1ADq9q5AxusMWHGu0oi0Om0pAKFJbv7arYcMuWezI6eaIJhr9K7nrRrMyvU9qxIneWYdUlcpKFT7XEf4G4%2BaQ1NNn2caG65a6NEnwkQ1K7W37%2BxBeXUDyp7jd1YXEmhCQ3yPsE0q53fMShy%2FLJGxaWonT0Bjwv4ZH7yS%2BNIzdIJopvvf0gWWEKSilD24ewUlNMdJZuBFej0C18UIYYoHIsUmt1B40wt3ywYH1mQieg7UJWbwwwKWx7gU6zwIGjzwSytCwTu33wnXXdsGEwT4Wi5p2cSQK873DDJy1tIMdoYvJUk1mQjs5pEsBhOmLa9sLLHnRPebC6WHzIjZKTSUixuAVrM%2BA72yCgAMQiRuLnhv7u0p2HSEGwLWhiSTMxrazdFMkLZzLdiHgd%2FxX%2FNIhWWslcqF%2BkiXXaWRTvjJdg2tC1Gi8AbgsI2lSYJUmhu%2BtUXRMViilI5p2dUHNxN%2F%2FZlOoHZUUeDuqONU4BuOBYegX6m4XzqBfS45j0yBkf5ILUPCFICS1V1EZl4nRvp0nAJDvNUR%2Fm66mMHV9TH4aa7zaxJ0B2BXjb6uzmcuxpbFw717fE%2B6vLKLRRNENuv5r86X3jeUhFTxT5okziNIaUNUM2ILcOxT7%2FAv3b3Eu7uuuKvv%2BGz2GgLWbwZC4E1q5gks6Gxif6weSTk33Pg0i%2BrRARFlAuk0915qJMA%3D%3D&host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61&X-Amz-Expires=300&hash=772ef6e3bfe853fc6bfd28d8cb6ec1197ec2c9770b2421695be57c6b1157dd98
No data is associated with this publication.
Abstract

Age-related human hematopoietic stem cell (HSC) exhaustion and myeloid-lineage skewing promote oncogenic transformation of hematopoietic progenitor cells into therapy-resistant leukemia stem cells (LSCs) in secondary acute myeloid leukemia (AML). While acquisition of clonal DNA mutations has been linked to increased rates of secondary AML for individuals older than 60 years, the contribution of RNA processing alterations to human hematopoietic stem and progenitor aging and LSC generation remains unclear. Comprehensive RNA sequencing and splice-isoform-specific PCR uncovered characteristic RNA splice isoform expression patterns that distinguished normal young and aged human stem and progenitor cells (HSPCs) from malignant myelodysplastic syndrome (MDS) and AML progenitors. In splicing reporter assays and pre-clinical patient-derived AML models, treatment with a pharmacologic splicing modulator, 17S-FD-895, reversed pro-survival splice isoform switching and significantly impaired LSC maintenance. Therapeutic splicing modulation, together with monitoring splice isoform biomarkers of healthy HSPC aging versus LSC generation, may be employed safely and effectively to prevent relapse, the leading cause of leukemia-related mortality.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item